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The Delayed type hypersensitivity skin test (DTH) and interferon-gamma assay are used for the diagnosis of bovine tuberculosis
(TBB). The specificity of these diagnoses, however, is compromised because both are based on the response against purified
protein derivative of Mycobacterium bovis (PPD-B). In this study, we assessed the potential of two cocktails containing M. bovis
recombinant proteins: cocktail 1 (C1): ESAT-6, CFP-10 andMPB83 and cocktail 2 (C2): ESAT-6, CFP-10,MPB83, HspX, TB10.3, and
MPB70. C1, C2, and PPD-B showed similar response by DTH inM. bovis-sensitized guinea pigs. Importantly, C1 induced a lower
response than PPD-B inM. avium-sensitized guinea pigs. In cattle, C1 displayed better performance than PPD-B andC2; indeed, C1
showed the least detection of animals either vaccinated or Map-infected. To optimize the composition of the cocktails, we obtained
protein fractions from PPD-B and tested their immunogenicity in experimentally M. bovis-infected cattle. In one highly reactive
fraction, seven proteins were identified. The inclusion of FixB in C1 enhanced the recognition of M. bovis-infected cattle without
compromising specificity. Our data provide a promising basis for the future development of a cocktail for TBB detection without
interference by the presence of sensitized or infected animals with other mycobacteria.
1. Introduction
The infection and disease produced byMycobacterium bovis,
which is the causative agent of bovine tuberculosis (TBB),
is an important problem in cattle and other animal species.
Human tuberculosis (TB) is produced mainly by Mycobac-
terium tuberculosis. However,M. bovis can also be responsible
for the disease in humans, which makes this bacterium
an important zoonotic species [1]. The TBB eradication
programs in Argentina are based on a prompt detection of
infected animals and their subsequent removal from the herd.
Delayed type hypersensitivity skin test (DTH), which is
based on response against single intradermal inoculation of
purified protein derivative ofM. bovis (PPD-B), remains the
primary surveillance tool to diagnose TBB in our country.
The intensity of DTH reactions elicited inM. bovis-sensitized
guinea pigs is the model to select batches of PPD-B to be
used in the field. Thus, this animal model could be used to
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evaluate reagents with potential for TBB diagnosis. Disease
control can also be facilitated by using the interferon-gamma
(IFN-𝛾) assay. In their original form, these tests, DTH and
IFN-𝛾, are based on the response against PPD-B.This reagent
is a mix of proteins, lipids, and carbohydrates obtained
from heat-killed cultures of M. bovis strain AN5, which
compromise specificity because some of its antigenic com-
ponents are present in others nonpathogenic and pathogenic
mycobacteria [2, 3]. Animals infected with Mycobacterium
avium subsp. paratuberculosis (Map), the etiologic agent
of paratuberculosis (PTB), or vaccinated with BCG have
demonstrated positive response in these assays using PPD-
B. The specificity of these tests can be increased with the use
of definedM. bovis antigens.
Many mycobacterial proteins have been isolated and
eval-uated in DTH and IFN-𝛾 assays in animals with TBB
[4–13]. For instance, ESAT-6 (Rv3875 or EsxA) is one of the
major antigenic targets identified in both cattle and humans
with tuberculosis [14]. Several other antigens with molecular
masses of around 10 kDa and belonging to the Esx family of
proteins have been identified subsequently, such as CFP10
(RV3874 or EsxB) and TB10.3 (Rv3019c or EsxR), and they
have been shown to be equally well recognized by T cells
[15]. ESAT-6 and CFP-10, or combinations of these antigens,
have been extensively tested by DTH and IFN-𝛾 assays in
naturally M. bovis-infected cattle with satisfactory results
[16–19]. The studies performed in M. bovis-infected cattle
yielded promising results with cocktails containing ESAT-6,
CFP-10 plus the addition of other antigens [18–20]. ESAT-
6 and CFP-10 are encoded in a genomic region, RD1, that
is absent in BCG Pasteur and, thus, are useful as diagnostic
tools for differentiating TB-infected from BCG-vaccinated
animals (DIVA) [19]. Proliferative immune response with
synthetic peptides derived from the sequences of CFP-10
and ESAT-6 showed that BCG-vaccinated cattle did not
respond to this peptide cocktail, whilst they all responded to
PPD-B [21].
Furthermore, the use of a recombinant ESAT-6: CFP-10
fusion protein was useful to differentiate M. bovis-infected
from those Map-infected cattle [22]. Several studies have
identified immunogenic proteins present in bothM. bovis/M.
tuberculosis [4, 9, 10, 15, 17]. A disadvantage of those studies,
however, is that they are restricted to a relatively small set
of proteins biased by the initial selection criteria. Recently,
a nonbiased approach with an extensive library of clones
expressing mycobacterial proteins was used and 33 gene
products that induced IFN-𝛾 production in whole-blood
cultures from TB-reactor animals were detected. One of
these proteins did not induce responses in BCG-vaccinated
animals, which is suitable for DIVA diagnostic. Greater
responder frequencies were observed for BCG-vaccinated
cattle than for TB reactors with the remaining antigens,
which leads to speculate that other “less immunodominant”
antigens maybe recognized to a greater extent in BCG-
vaccinated animals [23].
These recent studies show that the search of other
antigens for a more sensitive and specific diagnosis of TB
is still relevant. Unfortunately, few studies have shown the
feasibility ofM. bovis antigens to increase specificity of DTH
using either the guinea pigmodel or experimentallyM. bovis-
infected cattle [24–26]. Moreover, even more information
of the use of cocktails with M. bovis antigens in naturally
infected cattle remains scarce.
The present study aimed to assess cocktails containing
previously defined antigens of M. bovis in order to differ-
entiate animals with TBB from vaccinated- or Map-infected
animals. For this purpose,we used different approaches:DTH
in the guinea pig model and both DTH and IFN-𝛾 assays in
the cattle model. The specificity of the defined antigens was
evaluated in both BCG-vaccinated and Map-infected cattle.
Finally, novel cocktails enriched with immunogenic proteins
identified bymass spectrometry analysis of selected antigenic
fractions of PPD-B were evaluated in TBB, PTB, and free
herds.
2. Material and Methods
2.1. Antigens. In the first part of the present study, we assessed
the application of antigens that have been extensively tested
in TBB with satisfactory results. These antigens were used
to produce two cocktails: cocktail 1 (C1) containing ESAT-
6, CFP-10, and MPB83 and cocktail 2 (C2) with ESAT-6,
CFP-10, MPB83, MPB70, TB10.3, and HspX. The potency of
the cocktails was evaluated by DTH in M. bovis, M. avium
sensitized-guinea pigs, and nonsensitized guinea pigs, as well
as in experimentallyM. bovis-infected cattle (DTH and INF-
𝛾), BCG-vaccinated, naturally Map-infected cattle, and in a
free TBB and Map herd by IFN-𝛾.
The purified recombinant proteins, ESAT-6, CFP-10,
MPB70, MPB83, TB10.3, and HspX, were kindly provided by
Professor Mahavir Singh (Lionex Diagnostics andTherapeu-
ticsGmbH,Germany). In all cases, the endotoxin content was
<1.27 IU/mg.
In the second part, we characterized immunodominant
antigens from the PPD-B. The coding sequences of
CFP2, FixB, and PepA were amplified by PCR using the
following primers: CFP2-fw 5󸀠-cgcggatccatgaagatggtgaaa
tcga-3󸀠(BamHI site) and CFP2-rev 5󸀠- ataagctttcagttccctgcg
gcctgc-3󸀠(HindIII site); FixB-fw 5󸀠-cgggatccatggctgaagtac
tgg-3󸀠(BamHI site) and FixB-rev 5󸀠-taagcttctagcccttgcgggcc-
3󸀠 (HindIII site); PepA-fw 5󸀠-aaggatccatgagcaattcgcgccg-
3󸀠(BamHI site) and PepA-rev 5󸀠-ataagctttcaggccgggggtccct-
3󸀠(HindIII site). M. bovis DNA was employed as template
for the amplifications. The amplification programme was
as follows: an initial step of 95∘C for 10min, 35 cycles of
95∘C for 1min, 58∘C for 1min, and 72∘C for 1min followed
by a final termination step of 72∘C for 8min. The complete
open reading frames of CFP2 (507 pb), FixB (957 pb), and
PepA (1068) were subsequently cloned into the expression
vector pRSET-A (Invitrogen BV, Leek, The Netherlands).
The derived constructions were transformed into Escherichia
coli BL21 (pLys) competent cells. A 3-mL inoculum of E. coli
BL21 harboring pRSET-A with the gene inserts was diluted
1/20 and grown to the mid-logarithmic growth phase
(OD of 0.6) in LB-ampicillin for 16 h at 37∘C. One mM
concentration of isopropyl-D-thiogalactopyranoside (IPTG)
(Merck, Germany) was added to induce recombinant gene
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expression over 3 h. Cells were then harvested by centrif-
ugation and frozen at −20∘C until further use. The cell pellet
was lysed with 1mL of lysis buffer (Tris-HCl 100mM pH
7.5, NaCl 300mM, Glycerol 20%, NP40 1%) using a Fast
Prep FP120 40 seg. 5.5m/s (Bio101-Savant, Holbrook, NY).
The expression of the soluble antigens was confirmed by
both Coomassie blue staining of polyacrylamide gels and
Western blot analysis using Mouse anti-His antibody as
primary antibody (GE Healthcare, UK) and anti-Mouse
Alkaline phosphatase as secondary antibody (Sigma,
Missouri, USA). The recombinant proteins in the E. coli
cell extracts were purified by using a Ni-NTA resin (Niquel
nitrilotriacetic acid) (Qiagen Corp., CA). For this purpose,
the supernatant was incubated for 90 minutes at 4∘C with
the resin and immobilized in the column. The resin was
then washed with lysis buffer and eluted with increasing
concentrations of imidazole (250mM, 500mM, and 1M)
(Sigma, St. Louis, MO) in buffer (Tris-HCl 50mM pH 7.5,
NaCl 500mM, Glycerol 20%, and NP40 1%). The presence
and purification of the protein was confirmed by Coomasie
blue and Western blot. The protein concentration was
estimated with the Micro BSA Protein Assay kit (Pierce,
USA).
PPD-B and PPD-A were obtained from the National Ser-
vice of Agricultural and Food Health and Quality (SENASA,
Buenos Aires, Argentina) with a protein concentration of
1mg/mL and 0,5mg/mL, respectively.
2.2. Gene Nomenclature and Identity of Antigens of C1 and C2.
The cfp-10 gene of M. bovis (Mb3904) has 100% identity to
cfp-10 of M. tuberculosis (Rv3874), which encodes a 10 kDa
culture filtrate antigen CFP-10 or EsxB.
The esat-6 gene of M. bovis (Mb3905) has 100% identity
to esat-6 ofM. tuberculosis (Rv3875), which encodes an early
secreted antigenic target 6 kDa, ESAT-6, or EsxA.
The genes cfp-10 and esat-6 are absent in the genome of
M. bovis BCG and Map.
MPB83 and MPB70 are highly homologous proteins
within M. tuberculosis complex members and the orthol-
ogous in different members of the complex are virtually
identical. However, they are major antigens that are highly
expressed by M. bovis and considerably less abundantly
expressed by M. tuberculosis. The mpb83 gene (Mb2898)
and mpb70 gene of M. bovis (Mb2900) have 100% identity
with their orthologous genes in M. tuberculosis (Rv2873 and
Rv2875, resp.).
The genesmpb83,mpb70, and hspX inM. bovis have 100%
identity with these genes inM. bovis BCG and they are absent
from Map’s genome. The hspX gene of M. bovis (Mb2057c)
has 100% identity with the gene (Rv2031c) that encodes the
16-kDa alpha crystalline (Acr) protein of M. tuberculosis or
heat shock protein X.
The TB10.3 or esxR gene ofM. bovis (Mb3045c) has 100%
identity with the gene (Rv3019c) of M. tuberculosis, which
encodes a secreted esat-6 like protein.
The protein TB10.3 ofM. bovis has 100% identity with this
protein inM. bovis BCG and 80% with the protein of Map.
2.3. Animal Models
2.3.1. DTH Skin Test in M. avium and M. bovis-Sensitized
Guinea Pigs. Two groups of guinea pigs were sensitized, one
with M. bovis, another with M. avium, by intramuscular
inoculation of 0.5mL of a sterile heat-killed suspension ofM.
bovis strain AN5 or heat-killed suspension ofM. avium strain
D4ER, respectively. A group of nonsensitized guinea pigs was
used to evaluate the specificity of the reagents. The sensitized
animals were prepared by clipping the hair from the entire
abdominal and flank areas. Thirty days after injection, the
guinea pigswere used for testing PPD-B, PPD-A,C1, C2, Esat-
6/CFP-10, and buffer phosphate saline (PBS) as a negative
control. On each guinea pig, six sites for injection of PPD-
B and the cocktails were selected. Three sites on each side of
themidline and spaced at a sufficient distance (2-3 cm aprox.)
from each other to avoid overlapping of skin reactions. The
induration diameter in guinea pig was read at 24 h, according
to protocol used by the National Service of Agricultural
and Food Health and Quality (SENASA), Buenos Aires,
Argentina.
C1 and C2 cocktails were prepared in PBS at a final con-
centration of 1 𝜇g/mL of each antigen. The animals received
intradermal injections with 0.2mL of each cocktail or PPD-B
and PPD-A at 1 𝜇g/mL.
2.3.2. Cattle
(1) BCG-Vaccinated and ExperimentallyM. bovis-InfectedCat-
tle. One group of five castrated male Holstein-Fresian calves
of three to four months of age was inoculated subcutaneously
in the side of the neck with 1 × 106 colony forming units
(CFU) of BCG Pasteur suspended in PBS. Another group of
six animals was infected with a wild boar virulent strain M.
bovis 04-303 by intratracheal instillation of 5 × 107 CFU as
described previously [27]. The strain M. bovis 04-303 is an
isolate obtained from a wild boar with tuberculous lesions
[28]. Briefly, this inoculation procedure was carried out by
anaesthetizing the calves with xylazine HCl (Rompun, Bayer,
Germany; 0.1mg/kg) intravenously and then inserting an
80 cm endotracheal tube into the trachea. A cannula was
inserted through the endotracheal tube.The 1.5mL inoculum
containing the M. bovis 04-303 was injected through the
cannula and flushed out with sterile saline equal to 10mL
volume.
All the animals used in this study were DTH negative to
both PPD-A and PPD-B at the beginning of the experiments.
These experimentally infected animals were part of a trial that
included evaluation of candidate TBB vaccines [27].
To confirm that the animals were successfully infected,
the calves were euthanized 100 days after infection and
then thin slices of lungs and lymph nodes of the head and
pulmonary region were analyzed in search of granuloma
formations. All M. bovis-infected animals presented macro-
scopic lesions and were positive for both bacterial isolation
and IS6110-PCR in both tissues [27].
Experimental vaccination and M. bovis infection were
performed inside the biosafety BSL3 facilities for animals of
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the National Institute of Agricultural Technology (INTA),
Argentina, in compliance with the regulations of the Ethical
Committee of INTA (CICUAE) and the biosafety protocols
as authorized by the National Service of Agricultural and
Food Health and Quality (SENASA).
(2) Naturally Map, M. bovis-Infected Cattle, and Free TBB and
PTB Herd. For the purpose of verifying the TBB cocktails
specificity by IFN-𝛾 assay, we used blood samples of 10
and 17 animals from 2 dairy herds with PTB confirmed by
fecal culture. The selected animals were positive by DTH for
PPD-A.
A total of 58 animals from M. bovis-infected beef herd
were 27 DTH positive (induration reaction ≥ 5mm), 19
displayed intermediate reaction (1–3mm) and 12 animals
were DTH negative.
As a negative control 10 animals from a free TBB and PTB
herd were used for IFN-𝛾 release assay.
2.4. Evaluation of C1 and C2 in BCG-Vaccinated, Experiment-
ally M. bovis-Infected and Naturally Map-Infected Cattle
by IFN-𝛾 Release Assay. Blood samples from infected and
vaccinated cattle were collected from the jugular vein into
heparinized vials at 20, 30, 60, and 90 days after M. bovis
infection (dpi) and 30 and 60 days after BCG vaccina-
tion (dpv). These samples were used to evaluate cocktails
and fractions from PPD-B by IFN-𝛾 release assay using a
commercial ELISA-based kit (Bovigam; Prionics, Shlieren,
Zurich, Switzerland). Briefly, aliquots of 200𝜇L of bloodwere
added in a 96-well culture microplate and incubated with
25 𝜇L of antigenic preparations per duplicate. Each of the
constituent proteins was added to the cocktails at a concen-
tration of 55𝜇g/mL and the PPD-B peptidic fractions were
used at a concentration of 36 𝜇g/mL of total protein. PPD-A
and PPD-B were used at a final concentration of 50𝜇g/mL.
Negative-control wells with PBS alone were included for
each tested animal. As positive control, 4.5 𝜇g/mL pokeweed
mitogen (Sigma-Aldrich, United Kingdom) was used. The
plates were incubated in a humidified 5% CO
2
incubator at
37∘C for 16 h. Stimulated plasma was obtained by centrifu-
gation and IFN-𝛾 concentrations in plasma were determined
following the manufacturer’s procedures. Color development
was measured at 450 nm and the results were expressed as
optical density (OD) indices (ODIs) (ODI = OD for antigens
stimulated cultures/OD for PBS stimulated cultures). An
ODI equals or higher than 2 was considered positive. The
coefficient of variation between duplicate wells was less than
5%, and the OD for the control wells was usually less than 0.1.
Also, blood samples of 17 animals from a dairy herd with
PTB, positive to DTH with PPD-A, were stimulated with C1,
C2, PPD-A, or PPD-B to test specificity in the IFN-𝛾 release
assay.
2.5. DTH Skin Test in Experimentally M. bovis-Infected Cattle.
The experimentally M. bovis-infected animals were tested
by DTH before and after infection. Before infection, all the
animals used in this study were DTH negative using PPD-
B (<1mm). The cattle were reevaluated by DTH 90 days
after M. bovis challenge, using C1, C2, and PPD-B. The
cocktails for DTH were prepared with 10 𝜇g of each antigen
per 0.1mL in PBS and 100 𝜇g per 0.1mL of PPD-B. Animals
were intradermally injected with 0.1mL of C1, C2, or PPD-
B (1mg/mL) and the thickness of the caudal fold tuberculin
skin test was measured using callipers before and 72 h after
injection.
2.6. Antigen Identification in PPD-B Fractions. PPD-B was
prepared and fractionated in order to identify new antigens
components of the PPD-B capable to improve the immuno-
logical cellular response in animalswithTBB. Briefly,M.bovis
strain AN5 was cultured in modified Dorset-Henley medium
for 8 to 10 weeks.The cultures were inactivated by autoclave at
100∘C for 3 hours and the proteins were concentrated using a
Pellicon XI device (Millipore Corporation, Bedford, MA) for
tangential flow filtration.
2.6.1. Separation of Protein Fractions from PPD-B. PPD-B
proteins were divided into narrow molecular mass fractions
by continuous elution of polyacrylamide gels as described
previously [29]. Briefly, PPD-B preparation was resuspended
in cracking buffer (SDS 2%, Tris HCl 0.125M pH 6.8, 2-
mercaptoethanol 1%, bromophenol blue 0.02%, and glycerol
10%), heated for 5min in boiling water, and resolved by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis
12% (SDS-PAGE). Thirty fractions were collected using a
whole-gel elutor (Bio-Rad Corporation). The protein con-
centration of the different fractions was estimated by the
micro BSA Protein Assay kit (Pierce, USA). The fractions
were dialyzed against PBS and kept frozen at −80∘C until
used.
2.6.2. Identification of New Antigens from Bovine PPD Frac-
tions by Mass Spectrometry. PPD-B fractions were evaluated
for their capability to stimulate IFN𝛾 release as previously
described and the proteins present in the selected fractions
with higher ODIs were identified by mass spectrometry.
The selected samples were digested with sequencing-grade
trypsin (Promega) by incubation at 35∘C overnight. Prior to
MS analyses, the digested samples were desalted using C18
reverse phase microcolumns (Omix Tips, Varian). Briefly,
columns were preequilibrated with 20 𝜇L of an aqueous
solution of 0.1% trifluoroacetic acid (TFA). After sample
loading, microcolumns were washed with 0.1% TFA and
eluted with 0.1% TFA in 60% acetonitrile.
The samples were evaporated in the speed vac, resus-
pended in 12 𝜇L of 0.05% formic acid and then injected in
a nanoLC equipment (Proxeon easynLC, Thermo Scientific).
Peptide separation was performed in a reverse-phase column
(easy C18 column, 3𝜇m; 75 𝜇m ID×10 cm; Proxeon,Thermo
Scientific) and peptides were eluted using a 0.1% (v/v) formic
acid in water 0.1% (v/v) formic acid in acetonitrile gradient
(0–60% acetonitrile in 60min; flow 400 nl/min). Online MS
detection/analysis was carried out in a linear ion trap mass
spectrometer (LTQ Velos, Thermo Fisher Scientific Corp.,
USA) with nanospray ionization. Proteins were identified by
NCBInr database searching (November 2009) with peptide
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Figure 1: DTH response induced by PPD-A, PPD-B, C1, C2, ESAT-6/CFP-10, and PBS in guinea pigs previously sensitized with M. avium
(a) or M. bovis (b). Responses were measured at 24 hs. Statistical differences between responses were found by using Kruskall Wallis test.
( ∗∗𝑃 < 0.01; ∗𝑃 < 0.05).
m/z values using theMASCOT search engine (version 2.3.02)
in the MS/MS ion search mode and the following search
parameters: taxonomy Mycobacteriun tuberculosis complex;
peptide tolerance 1.5 Da; fragmentmass tolerance 0.8Da; and
methionine oxidation as the allowed variable modification.
Significant protein scores and individual ion score (𝑃 < 0.05)
were used as criteria for positive protein identification.
2.6.3. Evaluation of Novel Enriched C1 by IFN-𝛾. The per-
formance of the enriched C1 with the recombinant antigens
identified from highly reactive fractions of PPD-B (novel
cocktails C1 + FixB, C1 + CFP2) was assessed using blood
from a beef herd with high prevalence of TBB (𝑛: 58) by IFN-
𝛾 release assay. In addition, we also used blood samples from
a dairy herd with PTB (𝑛: 10) and from a TBB and PTB free
herds (𝑛: 10).
3. Results
3.1. Evaluation of the Biological Potency of C1 andC2 inGuinea
Pigs. We initially assessed the application of antigens that
have been extensively tested in TBB with satisfactory results.
These antigens were used to produce two cocktails: cocktail
1 (C1) containing ESAT-6, CFP-10, and MPB83 and cocktail
2 (C2) with ESAT-6, CFP-10, MPB83, MPB70, TB10.3, and
HspX. The C1 and C2 were first tested in M. bovis- and M.
avium-sensitized guinea pigs by DTH reaction by detection
of swelling 24 hs after inoculation at the site of injection. The
reactions in M. bovis-sensitized guinea pigs were similar to
PPD-B when C1 or C2 was injected (Figure 1(b)). However,
inM. avium-sensitized guinea pigs PPD-B had higher values
than C1 (Figure 1(a)). Then C1 is a potential specific reactive
for diagnosis of TBB (Figure 1). In order to evaluate if
the addition of MPB83 to ESAT-6/CFP-10 compromises the
specificity of C1 we tested ESAT-6/CFP-10 without MPB83.
The response was not significantly different in M. avium-
sensitized guinea pigs, and then we could infer that the
addition of MPB83 to C1 would not compromise differential
diagnosis.
When all the antigens were assayed in a group of nonsen-
sitized guinea pigs, no reactionwas detected (data no shown).
3.2. C1 and C2 Evaluation by IFN-𝛾 Release in Experi-
mentally M. bovis-Infected, BCG-Vaccinated, Naturally and
Map-Infected Cattle. The relative amounts of IFN-𝛾 were
measured stimulating blood from experimentally M. bovis-
infected bovines using C1, C2, PPD-A, and PPD-B. No sig-
nificant differences were found at 30, 60, and 90 dpi between
C1, C2, and PPD-B. However, C1 and PPD-B stimulated
higher values of IFN-𝛾 than C2 20 dpi (Figure 2(a)). In BCG-
vaccinated animals (𝑡 = 30 and 60 dpv), no significant
differences were detected between the three antigens. How-
ever, prior vaccination (𝑡 = 0), IFN-𝛾 levels were above 2
when blood was stimulated with PPDB (Figure 2(b)). For the
purposes of this study, an ODI equals or higher than 2 was
considered positive.
Regarding the relative amounts of IFN-𝛾 induced by C1,
C2, and PPD-B in naturally Map-infected cattle, PPD-B and
C2 detected 6/17 and 4/17 positive animals, respectively, while
C1 detected only one (Figure 3). These results demonstrated
that C1 is more specific for TBB diagnosis than C2 and PPDB,
since this cocktail was effective in suppressing the detection
of animals infected with other mycobacteria.
3.3. C1 and C2 Evaluation by DTH in Experimentally M.
bovis-Infected Cattle. M. bovis-infected cattle were tested for
DTH 90 dpi, using C1, C2, and PPDB as antigens. Values at
the induration area were significantly lower when injecting
C1 and C2 than swelling at the site of injection of PPD-B.
However, if skin test is considered as positive (values above
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Figure 2: IFN-𝛾 responses induced by PPD-A, PPD-B, C1, and C2 in experimentallyM. bovis-infected cattle (𝑛 = 6) (a) and BCG-vaccinated
animals (𝑛 = 5) (b) at different times. The cocktails were tested at a concentration of 55 𝜇g/mL per constitutive protein, PPD-A and PPD-
B with concentration of 50𝜇g/mL. Aliquots of 25 𝜇L of each antigenic preparation were added to 200 𝜇L of blood samples. The results are
expressed as mean of ODIs with standard errors. Statistical differences between responses were found by using MannWhitney test. ∗: differs
(𝑃 < 0.05) from PDD-A and C2 values at 20 dpi for both PPD-B and C1. +: differs (𝑃 < 0.05) from PPD-A values at 60 and 90 dpi for PPD-B,
C1, and C2.
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Figure 3: IFN-𝛾 responses induced by PPD-A, PPD-B, C1, and C2
in naturally Map-infected cattle (𝑛 = 17). The cocktails were tested
at a concentration of 55 𝜇g/mL per constitutive protein. PPD-A and
PPD-B were assessed with concentration of 50𝜇g/mL. Aliquots of
25 𝜇L of each antigenic preparation were added to 200 𝜇L of blood
samples. The results for each animal are represented by different
figures and the horizontal line provides the mean of the ODIs. The
dashed line represents the cutoff values used for positivity.
5mm), C1 andC2 detected 5/6 reactors to PPD-B inM. bovis-
infected animals (Figure 4).
It is worth to mention that C1 and C2 were intradermally
injected at a concentration of 10 𝜇g of each antigen per 0.1mL
in PBS, while PPD-B was inoculated at 100 𝜇g/0.1mL. This
higher concentration could be responsible for the differences
to the reactions in response to PPDB.
3.4. Evaluation of PPD-B Fractions by IFN-𝛾 in Experimen-
tally M. bovis-Infected and BCG-Vaccinated Animals. Thirty
protein fractions with molecular masses ranging from <17
to 90 kDa were obtained by electroelution of PPD-B in a
12% SDS-PAGE.These fractions were used to stimulate blood
from experimentally M. bovis-infected and BCG-vaccinated
cattle by IFN-𝛾 release assays. All fractions were tested
with blood taken at 0 and 20 dpi. We observed that PPD-
B fractions with the lowest molecular masses were more
antigenic.Therefore, these samples were further checkedwith
blood taken at 30, 60, and 90 dpi. (Figure 5). These samples
were also used to test blood from BCG-vaccinated cattle
by IFN-𝛾 release tests. Blood was collected at 30 and 60
dpv and most PPD-B fractions showed low levels of ODI
(Figure 6). The fractions 21, 23, and 24 were selected for
protein identification.
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Figure 4: DTH response induced by PPD-B, C1, and C2 in exper-
imentally M. bovis-infected cattle to 90 dpi (𝑛 = 6). The cocktails
were prepared with 10𝜇g of each antigen per 0.1mL in PBS and
PPD-B 100 𝜇g per 0.1mL. The animals were intradermally injected
with 0.1mL of C1, C2, or PPD-B (1mg/mL) and the thickness of
the caudal fold tuberculin skin test was measured using callipers
prior and 72 h after injection. Animal responses were represented
by boxes and the horizontal line provides the median with standard
errors. The statistical difference between responses was determined
by using Kruskall Wallis test ( ∗∗𝑃 < 0.01).
3.5. Protein Identification from Selected PPD-B Fractions by
Mass Spectrometry. Selected fractions were analyzed by mass
spectrometry to identify individual proteins. The three frac-
tions were subjected to the LC-MS/MS but only one fraction
(number 23) allowed the identification of seven putative
antigens: CFP10, CFP2, MPB70, MPB83 FixB, PepA, HspX,
and a partial sequence of an unknown protein (Table 1).
CFP10, MPB70, MPB83, and HspX are known as antigenic
proteins andwere already included in C1 or C2. CFP2 belongs
to the CFP protein family which is the founding member of
the family; CFP10 is a putative secreted protein that may play
a role in the development of protective immune response.
FixB is an electron transfer flavoprotein that functions as
a specific electron acceptor for other dehydrogenases. PepA
is a probable serine protease. Finally, the detected partial
sequence yielded significant alignments with a possible trans-
port protein, SecE2 (M. tuberculosisRv0379), with a sequence
identity of 60% (70/116 aa).
3.6. Evaluation of the Novel Recombinant Mycobacterial Pro-
teins from PPD-B Fractions. The genomic sequences corre-
sponding to cfp2, fixb, and pepa were cloned, expressed, and
purified as described above. We first checked the specificity
of the antigens by IFN-𝛾 in Map-infected animals. CFP2
and FixB did not detect any animals with PTB, while PepA
detected 2 animals in a herd with PTB (data not shown).
Based on our results, C1 displayed better performance
diagnostic than PPD-B and even better than C2 by IFN-𝛾
assay; indeed, C1 detected animals with TBB and showed the
least detection of animals either vaccinated or infected with
Map. Thus, we prompted to improve C1 with the addition of
the recombinant proteins, CFP2 or FixB.
The novel cocktails were tested in 58 animals from a
herd with TBB. According to the average value of IFN-𝛾,
the response to PPD-B was similar to that of C1 with FixB
(average ODI = 3) (Figure 7). PPD-B detected 33/58 animals,
while C1 detected 24/58 animals suspected to be infected
with M. bovis. The addition of FixB to C1 improved the
results, detecting 29/58 animals. By contrast, the addition of
CFP2 did not yield better results, detecting 22/58 (Figure 7,
Table 2).
Most importantly, C1, C1 plus FixB and C1 plus CFP2 did
not detect animals neither in a PTB herd nor in healthy cattle
(Figures 8 and 9). Thus, the inclusion of FixB in C1 enhanced
the recognition of naturally M. bovis-infected cattle without
compromising specificity.
4. Discussion
Several immunodominant proteins identified fromM. tuber-
culosis and M. bovis have been identified by comparative
genomics [4], differential transcription rates [5], or gene
expression profiles associated with latent mycobacterial
infection [6, 7]. Others have been detected from members of
the PE/PPE family [8], proteins from crude protein fractions
of M. bovis, and potentially secreted proteins. Within these
potentially secreted proteins, we canmentionmembers of the
Esx family, such as ESAT-6, CFP-10, and TB10.3 (Rv3019c)
[10, 11, 15].
CFP-10, ESAT-6, and TB10.3 are members of a large
family ofmycobacterial proteins, typically consisting of about
100 amino acids and are characterized by their organization
in pairs within the genome [30]. Members of this family
have been identified as potent T-cell antigens [15, 31]. Our
group has previously participated in a multilaboratory study
that assessed the sensitivity and specificity of the IFN-𝛾
assay using several antigens in cattle naturally infected with
M. bovis from Northern Ireland, Mexico, and Argentina.
These regions have low, medium, and high prevalence of
TBB, respectively. In the three countries, ESAT-6 and CFP-
10 performed as superior diagnostic antigens [16]. Other
previous studies have demonstrated that antigens ofM. bovis,
such asMPB70 andMPB83, also induced strong proliferation
and IFN-𝛾 responses in vitro in M. bovis-infected animals,
while BCG-vaccinated or M. avium-sensitized animals did
not respond to these antigens [19].These results thus confirm
that MPB83 and MPB70 also might be suitable antigens
to differentiate between animals with TBB from animals
with PTB- or BCG-vaccinated as well as from animals
vaccinated against PTB. MPT83 (Rv2873) is a cell wall-
associated lipoglycoprotein ofM. tuberculosiswhose function
is still unknown. However, this protein has been suggested
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Figure 5: IFN-𝛾 responses induced by PPD-B fractions in experimentally M. bovis-infected cattle (𝑛 = 6). PPD-B fractions were tested
at a concentration of 36 𝜇g/mL. Aliquots of 25 𝜇L of each fraction were added to 200 𝜇L of blood samples. The results for each animal are
represented by different vertical lines.The fractions were first tested with blood of animals from 0 and 20 dpi.The fractions that displayed the
more stimulant responses were tested again at 30, 60, and 90 dpi.
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Figure 6: IFN-𝛾 responses induced by PPD-B fractions in BCG-vaccinated cattle (𝑛 = 5). PPD-B fractions were tested at a concentration of
36 𝜇g/mL. Aliquots of 25 𝜇L of each fraction were added to 200 𝜇L of blood samples. The results for each animal are represented by different
vertical lines. The fractions were tested with blood of animals taken at 0, 30, and 60 dpv.
Table 1: Identified antigens from PPD-B by mass spectrometry.
Accession number Rv Mb Proteins Score Length (aa)
gi 15611010 Rv3874 Mb3904 10 kda culture filtrate antigen EsxB or CFP10 182 100
gi 149926 Rv2875 Mb2900 MPB70 135 193
gi 2149409∗ Unknown 113 116
gi 15609513 Rv2376c Mb2397c Low molecular weight antigen CFP2 102 168
gi 15610165 Rv3028c Mb3054c Electron transfer flavoprotein subunit alpha FixB 85 318
gi 15607267 Rv0125 Mb0130 Serine protease PepA 70 355
gi 248681∗∗ MMP = 19 kDa major membrane protein [M.tuberculosis Erdman strain 107] 73 143
gi 6469702 Rv2873 Mb2898 MPB83 (Mycobacterium tuberculosis) 63 220
∗Sequence producing significant alignments with the protein of M. tuberculosis Rv0379, possible protein transport protein SecE2, with identities in 70 from
116 aa.
∗∗Sequence producing alignments with HspX ofM. tuberculosis/M. bovis.
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Table 2: Number of recognized naturallyM. bovis infected animals
by the different antigens by IFN-𝛾 release assay.
Antigen Number of positive animals by IFN-𝛾/total
PPD-B 33/58
C1 24/58
C1 + FixB 29/58
C1 + CFP2 22/58
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Figure 7: IFN-𝛾 responses induced by PPD-A, PPD-B, C1, C1
plus FixB and C1 plus CFP2 in cattle from a herd with TBB
(𝑛 = 58). The cocktails were tested at a concentration of 55𝜇g/mL
per constitutive protein, PPD-A and PPD-B with concentration of
50 𝜇g/mL. Aliquots of 25 𝜇L of each antigenic preparation were
added to 200 𝜇L of blood samples. The results for each animal are
represented by different markers and the horizontal line provides
the mean of the ODIs. The dashed line represents the cutoff values
used for positivity.
to play a role in adhesion and dissemination based on seq-
uence analysis. Its homologue in M. bovis, MBP70, is also
a serodominant antigen during M. bovis infection in cattle.
MPB83 and MPB70 are major antigens highly expressed by
M. bovis and considerably less abundantly expressed by M.
tuberculosis [32–34].
In a prior study in our laboratory, eleven proteins were
detected during the evaluation of the fractions from filtrate
and cell extracts from M. bovis that elicited IFN-𝛾 response
in animals with TBB. Among the detected proteins, EsxI and
HspX triggered a high T cell immune response as measured
by IFN-𝛾 release assay [9].
According to these previous results we selected the
recombinant proteins included in each cocktail. Initially,
cocktails composed of purified recombinant M. bovis/M.
tuberculosis antigenic proteins HspX, TB10.3, ESAT-6, CFP-
10, MPB70, and MPB83 were formulated. C1 contained
the following proteins: ESAT-6, CFP-10, and MPB83 and
C2 contained ESAT-6, CFP-10, MPB83, HspX, TB10.3, and
MPB70.
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Figure 8: IFN-𝛾 responses induced by PPD-A, PPD-B, C1, C1
plus FixB and C1 plus CFP2 in cattle from a herd with PTB
(𝑛 = 10). The cocktails were tested at a concentration of 55𝜇g/mL
per constitutive protein, PPD-A and PPD-B with concentration of
50 𝜇g/mL. Aliquots of 25 𝜇L of each antigenic preparation were
added to 200 𝜇L of blood samples. The results for each animal are
represented by different figures and the horizontal line provides the
mean of the ODIs. The dashed line represents the cutoff values used
for positivity.
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Figure 9: IFN-𝛾 responses induced by PPD-A, PPD-B, C1, C2, C1
plus FixB and C1 plus CFP2 in cattle from a free TBB and PTB herd
(𝑛 = 10). The cocktails were tested at a concentration of 55𝜇g/mL
per constitutive protein, PPD-A and PPD-B with concentration of
50 𝜇g/mL. Aliquots of 25 𝜇L of each antigenic preparation were
added to 200 𝜇L of blood samples. The results for each animal are
represented by different markers and the horizontal line provides
the mean of the ODIs. The dashed line represents the cutoff values
used for positivity.
When the potency of these cocktails was evaluated by
DTH in M. avium-sensitized guinea pigs, C1 was more spe-
cific than PPD-B. C1 did not show significant differences in
comparisonwith the response of CFP-10/ESAT-6; then in this
experience the inclusion ofMPB83 to C1 did not compromise
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differential diagnosis. However, oneM. avium-sensitized ani-
mal showed response against protein cocktail that included
ESAT-6 and CFP-10 antigens, absent in M. avium, but this
response was similar to the controls inoculated with PBS.
In addition, when using protein-antigen combination of
ESAT-6, CFP-10, and MPB83 in the IFN-𝛾 released assay,
C1 was highly sensitive and specific in the detection of
experimentally M. bovis-infected cattle. This combination
elicited no response in BCG-vaccinated calves and showed
the least detection of Map-infected animals. On the other
hand, C2 had poor IFN-inducing capacities in experimentally
M. bovis-infected cattle at 20 dpi. Despite the immunogenic-
ity of MPB70, Hspx, and TB10.3, their inclusion in C2 did
not increase the IFN-𝛾 response compared with the use of
only ESAT-6, CFP-10, and MPB83 at 20, 30, 60, and 90 dpi.
Since some of these antigens as ESAT-6 and CFP-10 are with
TB10.3 members of the same family and MPB70 and MPB83
are closely related sharing 73% protein sequence identity,
it is likely that their combination may result in antigen
redundancy. C1 formulated with dominant T cell antigens,
ESAT-6 and CFP-10, also contained MPB83. B antigens such
as MPB70 and MPB83 may still have a role in promoting
reaction initiation ofDTH response, thereby, can help to elicit
a better response to dominant effector antigens [13].
In the current study, 5/6 PPD-B reactors were also
positive to DTH skin reactions when using C1 and C2
as immunogens in experimentally M. bovis-infected cattle.
DTH response in experimentally M. bovis-infected cattle
was significantly higher when injecting PPD-B than when
using C1 or C2. This latter difference could be due to the
lower concentration of each protein, 10𝜇g in C1 and C2,
compared to 100 𝜇g of PPD-B. In previous field studies,
this concentration improved skin test responses without
compromising specificity [13, 17]. The results of this study
suggest that the doses of the recombinant proteins in the
cocktails C1 and C2 for tuberculin skin test may have to be
optimized.
The sensitivity of the DTH is less than 80%, which
makes it unlikely as an only diagnostic tool for an efficient
eradication of tuberculosis from a herd [35]. Therefore, in
spite of the higher cost and complexity, the IFN-𝛾 release
assay can be used as a complementary test to the intradermal
skin test, to confirm or discard the first results. The use of
C1 in the IFN-𝛾 release test demonstrated clear benefits since
less responses were obtained, when comparedwith PPD-B, in
BCG-vaccinated, orMap-infected calves; however, the results
confirmed that the specificity of the test is compromised,
when PPD-B is used as immunogen in cattle sensitized or
infected with other mycobacteria. A minimum difference in
the performance of C1 was observed between herds with
PTB (Figures 3 and 8); it could be attributed to different
environmental exposure. Finally, the addition of FixB to C1
resulted in higher sensitivity than C1, when evaluated in a
herd with TBB. On the other hand, the addition of CFP2 to
C1 did not result in a significant improvement in IFN-𝛾 assay
with C1.
Even though less animals were recognized with C1 plus
FixB compared with PPD-B, the novel cocktail was more
specific than PPD-B. Most important, in spite of the fact
that only 58 bovine with TBB were tested, the inclusion
of FixB in C1 enhanced the recognition of these naturally
M. bovis-infected cattle without compromising specificity
of IFN-𝛾 assay, demonstrated that a C1 plus FixB could
be suitable candidates for the development of diagnostic
reagents to either differentiate betweenM. bovis-infected and
MAP infected/BCG-vaccinated animal and then improve the
specificity of the diagnosis of TBB.
5. Conclusions
This study demonstrates that cocktails containing defined
M. tuberculosis complex antigens, such as ESAT-6, CFP-
10, MPB83, and FixB can provide a sensitive and specific
diagnosis of TBB. This finding is relevant, since a DIVA and
a differential diagnosis between animals with TBB and PTB
is needed. BCG vaccination could be applied in combination
with such DIVA tests, together with PTB vaccines. These
important proof-of-principle data provide a basis for future
optimization and improvement of protein concentration in
the novel cocktail.
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